The logo of Sanofi is seen at the company’s headquarters in Paris, France, January 31, 2022. REUTERS/Violeta Santos Moura/File Photo
LONDON: French drugmaker Sanofi will make 30 of its treatments, including insulin, available on a not-for-profit basis in 40 lower-income countries in the first step of its plan to increase access to its medicines worldwide.
The treatments will be provided under the new Impact brand, part of Sanofi’s global…
